Remove 2024 Remove Communication Remove Insurance Coverage and Processing
article thumbnail

Towards a healthier, more equitable and innovative Indian healthcare sector

Express Pharma

The Union Health Ministry received an allocation of about Rs 90,650 crores in the recent budget of 2024-25, a 12.5 The increased funding for Ayushman Bharat is a definite step towards moving closer to universal health coverage, and such coverage should include modern treatments such as TAVI/ TAVR involving valve implantation or replacement.

article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

The decision was communicated through a Department of Health and Human Services (HHS) press release. It provides evidence-based recommendations on the use of vaccines for children and adults, informs decisions about insurance coverage, and helps determine eligibility for publicly funded programs such as Vaccines for Children (VFC).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NHC Submits Comments on CMS’ Proposed Rule on Marketplace Integrity and Affordability

Putting Patients First Blog

Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses and organizations representing biopharmaceuticals, devices, diagnostics, generics, and payers.

article thumbnail

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

Pharmaceutical Technology

The approval process for cell and gene therapy candidates is tricky, however, given their high-cost and oft-debated benefit-risk ratio. RFK Jr did not question their importance, and acknowledged panellists’ calls for faster regulatory processes. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

article thumbnail

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

In 2024, Otsuka announced the acquisition of US-based Jnana Therapeutics in a deal worth up to $1.1bn. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. We may still continue to send you service-related and other non-promotional communications. Sign up for our daily news round-up!

article thumbnail

Considerations for Hernia Patients when Selecting a Surgeon

Putting Patients First Blog

Considerations for Hernia Patients when Selecting a Surgeon January 4, 2024 By: Abdominal Core Health Quality Collaborative Patient Engagement & Advocacy Committee & Abdominal Core Health Quality Collaborative Board of Directors Choosing a surgeon is a decision that can significantly impact patients’ health and well-being.

article thumbnail

NHC 2025 Notice of Benefit and Payment Parameters (NBPP) Comments

Putting Patients First Blog

NHC 2025 Notice of Benefit and Payment Parameters (NBPP) Comments January 16, 2024 Allen Pinn, Coordinator, Policy The National Health Council (NHC) submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding the 2025 Notice of Benefit and Payment Parameters (NBPP) on January 8.